All Roll Calls
Yes: 343 • No: 43
Sponsored By: Jr. Danny Earl Britt (Republican), Amy S. Galey (Republican), Benton G. Sawrey (Republican)
Signed by Governor
Personalized for You
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
12 provisions identified: 9 benefits, 1 costs, 2 mixed.
Beginning October 1, 2025, PBMs must let any properly licensed pharmacy join retail networks on the same terms. PBMs cannot charge network participation fees or require multiple specialty accreditations. Plans that limit participation must give all area pharmacies a written offer at least 60 days before the plan starts. PBMs must pay local pharmacies at least what they pay their own affiliates for the same drug per unit, counting rebates and fees. Insurers cannot cut a pharmacy’s pay because a member chose it, and rebates or incentives must be offered equally for the same volume and terms. If a PBM ends your contract, it still must pay for past, proper claims. Pharmacies may charge a small, disclosed shipping and handling fee for mailed prescriptions. For RFPs issued on or after October 1, 2025, the State considers PBM contract terms that protect local pharmacies, like parity and banning payments below acquisition cost.
For PBM contracts made, renewed, or changed on or after October 1, 2025, a PBM cannot require an independent pharmacy or a pharmacy in a pharmacy desert to take payment below the drug’s acquisition cost. Starting October 1, 2026, a PSAO cannot charge an independent pharmacy different drug prices based on what the pharmacy paid a wholesaler. Also starting October 1, 2026, a PSAO tied to a drug maker or distributor cannot force an independent pharmacy to buy only from that tied company.
Beginning January 1, 2027, your insurer must base copays and coinsurance on the drug’s price after rebates. The price used must be reduced by 90% of all rebates tied to that prescription. By January 1 each year, insurers must certify to the state that they followed this rule. Each day a filing is late counts as a separate violation.
Beginning October 1, 2025, your plan cannot stop you from choosing any participating pharmacy. Your copay or fees must be the same for the same benefit level. Plans cannot steer you with higher copays or penalties, except in pharmacy deserts or counties under 20,000 people. Plans cannot require mail‑order only. PBM networks must meet or beat Medicare Part D access rules. The state can penalize violators, and people and pharmacies can sue. PBMs also cannot share identifiable prescription data with affiliates in ways HIPAA forbids.
Prepaid Medicaid plans must use 100% of Medicaid fee‑for‑service methods to pay for ingredient cost and dispensing fees. NADAC plus a professional dispensing fee is the main method for non‑340B retail claims. 340B claims follow the CMS‑approved State Plan. This change is in effect now and ends June 30, 2026.
Auditors must give at least 14 days’ notice for on‑site audits and usually review only the last 24 months. They may examine the smaller of 0.1% of fills or 50 fills, with limited exceptions. Pharmacies generally face no more than one audit per year unless fraud is suspected and get 30 days to provide records. Before taking back money, auditors must give a summary with the total amount and a 7‑day window for the recoupment date. Breaking these audit rules is an unfair trade practice for audits on or after January 1, 2026.
The law applies all state drug‑coverage and unfair‑trade rules to PBMs, the same as insurers. PBMs must act in the insurer’s best interest, pass through rebates tied to the insurer’s money, and share claims data on request. Starting March 31, 2026, for contracts signed, renewed, or changed on or after October 1, 2025, PBMs that use spread pricing must report each quarter the gap between what they charge and what they pay pharmacies. Insurers must post these reports and share them with any employer customers. The Department of Insurance adopts PBM rules by October 1, 2025.
Starting October 1, 2025, PBMs with insurer contracts must file an annual report by May 1 with totals on rebates, spreads between plan and pharmacy payments, affiliate reimbursements, fees, and amounts passed through. These reports are confidential and cannot include personal data. By October 1 each year, the Board of Pharmacy must report statewide pharmacy counts and openings and closures over the past five years.
Beginning January 1, 2026, drug makers must report by January 31 each year any price increase of 15% or more on drugs priced $100 or more for a 30‑day supply. Makers must also report a new drug’s price within 3 days of first sale and share acquisition details within 30 days. The state will build an online portal and, starting January 1, 2027, publish a yearly report on the most used, most costly, and fastest‑rising drugs, and the top manufacturers by average increases. Companies may satisfy reporting through SEC filings, and the state treats submitted data as confidential trade secrets. DHHS enforces the rules and can fine up to $1,000 per day for not reporting.
Beginning October 1, 2026, PSAOs must be licensed and pay a $200 initial fee and a $150 annual renewal. PSAOs must give pharmacies copies of contracts and payment schedules within 10 days, pass through PBM remittances on schedule, and may not tie discounts to purchase volume. PSAOs must forward appeal notices quickly, share ownership details with the Department and counterparties, and disclose affiliated purchasing deals. A PSAO that breaks the law pays $500 per day after notice until it complies, and the Commissioner can revoke or refuse renewal.
Beginning October 1, 2026, any PSAO that negotiates for North Carolina pharmacies must be licensed by the Department of Insurance. The Commissioner sets the application and may charge initial and yearly renewal fees. PSAO reports to the Department are confidential, cannot include personal data about insured people, and are not public records. The Insurance Commissioner must adopt PSAO rules by October 1, 2026.
Beginning October 1, 2025, pharmacies and pharmacists cannot waive or discount your copay or coinsurance. Breaking this rule is professional misconduct under state pharmacy law.
Jr. Danny Earl Britt
Republican • Senate
Amy S. Galey
Republican • Senate
Benton G. Sawrey
Republican • Senate
Paul Newton
Republican • Senate
Lisa S. Barnes
Republican • Senate
Phil Berger
Republican • Senate
Woodson Bradley
Democratic • Senate
Bob Brinson
Republican • Senate
Jim Burgin
Republican • Senate
Jay J. Chaudhuri
Democratic • Senate
Jr. David W. Craven
Republican • Senate
Warren Daniel
Republican • Senate
Bobby Hanig
Republican • Senate
Ralph Hise
Republican • Senate
Mark Hollo
Republican • Senate
Brent Jackson
Republican • Senate
Steve Jarvis
Republican • Senate
Todd Johnson
Republican • Senate
Michael A. Lazzara
Republican • Senate
Tom McInnis
Republican • Senate
Timothy D. Moffitt
Republican • Senate
Brad Overcash
Republican • Senate
Bill Rabon
Republican • Senate
Norman W. Sanderson
Republican • Senate
Vickie Sawyer
Republican • Senate
Eddie D. Settle
Republican • Senate
All Roll Calls
Yes: 343 • No: 43
House vote • 6/26/2025
SB 479: SCRIPT Act.
Yes: 106 • No: 0 • Other: 10
Senate vote • 6/26/2025
SB 479: SCRIPT Act.
Yes: 42 • No: 0 • Other: 8
Senate vote • 6/19/2025
SB 479: SCRIPT Act.
Yes: 9 • No: 31 • Other: 10
House vote • 6/18/2025
SB 479: SCRIPT Act.
Yes: 96 • No: 12 • Other: 9
Senate vote • 5/7/2025
SB 479: SCRIPT Act.
Yes: 45 • No: 0 • Other: 3
Senate vote • 5/7/2025
SB 479: SCRIPT Act.
Yes: 45 • No: 0 • Other: 3
Ch. SL 2025-69
Signed by Gov. 7/9/2025
Pres. To Gov. 6/30/2025
Ratified
Ordered Enrolled
Conf Report Adopted
Added to Calendar
Conf Com Reported
Conf Report Adopted
Placed on Today's Calendar
Conf Com Reported
Conf Com Appointed
Conf Com Appointed
Failed Concur In H Com Sub
Placed On Cal For 06/19/2025
Special Message Received For Concurrence in H Com Sub
Special Message Sent To Senate
Passed 3rd Reading
Passed 2nd Reading
Added to Calendar
Cal Pursuant Rule 36(b)
Reptd Fav
Re-ref Com On Rules, Calendar, and Operations of the House
Reptd Fav Com Substitute
Re-ref to the Com on Health, if favorable, Rules, Calendar, and Operations of the House
Edition 1
Edition 2
Edition 3
Edition 4
Edition 5
Edition 6
Edition 7
Filed
Latest Edition
HB 696 — AN ACT TO PROMOTE HEALTH CARE PRACTITIONER TRANSPARENCY THROUGH ADVERTISEMENT REQUIREMENTS.
SB 449 — AN ACT TO REQUIRE ALL PUBLIC SCHOOLS, COMMUNITY COLLEGES, AND CONSTITUENT INSTITUTIONS OF THE UNIVERSITY OF NORTH CAROLINA TO REQUIRE MINIMUM CONSIDERATIONS ON TECHNOLOGY COSTS AND PUBLIC SCHOOLS TO REPORT ON BREAK/FIX RATE.
HB 926 — AN ACT TO PROVIDE FURTHER REGULATORY RELIEF TO THE CITIZENS OF NORTH CAROLINA.
HB 307 — AN ACT TO MODIFY TIME LIMITS ON MOTIONS FOR APPROPRIATE RELIEF IN NONCAPITAL CASES; TO PLACE XYLAZINE AND KRATOM ON THE CONTROLLED SUBSTANCE SCHEDULES; TO CREATE A NEW CRIMINAL OFFENSE FOR EXPOSING A CHILD TO A CONTROLLED SUBSTANCE; TO REQUIRE RECORDATION OF ALL CRIMINAL MATTERS IN DISTRICT COURT AND ESTABLISH WHEN THOSE RECORDS MAY BE DISCLOSED; TO REVISE LAWS PERTAINING TO THE DISCLOSURE AND RELEASE OF AUTOPSY INFORMATION COMPILED OR PREPARED BY THE OFFICE OF THE CHIEF MEDICAL EXAMINER; TO REVISE THE LAW GOVERNING THE GRANTING OF IMMUNITY TO WITNESSES; AND TO CLARIFY THE STANDING OF DISTRICT ATTORNEYS IN CERTAIN CASES.
HB 358 — AN ACT TO MAINTAIN NAIC ACCREDITATION OF THE DEPARTMENT OF INSURANCE BY IMPLEMENTING GROUP CAPITAL CALCULATION AND LIQUIDITY STRESS TEST REQUIREMENTS AND TO MAKE VARIOUS CONFORMING CHANGES, AS RECOMMENDED BY THE DEPARTMENT OF INSURANCE.
SB 55 — AN ACT TO REQUIRE REGULATION OF STUDENT USE OF WIRELESS COMMUNICATION DEVICES DURING INSTRUCTIONAL TIME.